| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.3 | 0.03 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.59 | 0.04 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |